top of page

Domestic:

+91 770 788 7676 

International:

+1 647 893 7323 

ETHDEC-50MG

Nandrolone 50mg

PACKING SIZE / TYPE

DISPO PACK 2ML

Summary

ETHDEC 50 MG Injection belongs to a group of medicines known as anabolic steroids (a man-made version of male sex hormone testosterone). The medicine is used for the treatment of anaemia and postmenopausal osteoporosis (a condition in which bones become fragile after the cessation of the menstrual cycles). ETHDEC 50 MG Injection works by promoting the growth of tissues and improving the production of proteins in the body.

ETHDEC 50 MG Injection may cause a few common side effects such as acne, oedema (swelling of legs, ankle, and feet), nausea, and breast enlargement. Talk to your doctor if any of these side effects bother you or do not subside. ETHDEC 50 MG Injection can be taken with or without food. The dosage of this medicine will be determined by the doctor based on your clinical condition.

ETHDEC 50 MG Injection is not recommended for use in people having kidney or liver problems, heart failure, prostate cancer, or porphyria (disorders that affect your body’s ability to make heme, a red pigment in your blood to which oxygen binds). Before initiating your treatment with this medicine, make sure to inform your doctor if you have any of these conditions.

ETHDEC 50 MG Injection is unsafe for use during pregnancy as it can severely harm the foetus. ETHDEC 50 MG Injection is not advised for breastfeeding mothers as it may affect the baby. Let your doctor know if you are pregnant or breastfeeding before taking this medicine. If you are a woman and develop symptoms like hoarseness, increased hair growth, acne, or increased sex drive after taking ETHDEC 50 MG Injection, make sure to consult your doctor.

Side Effects

Major & minor side effects for ETHDEC 50 MG Injection

  • Acne
  • Trouble sleeping
  • Chills
  • Impaired liver function
  • Nausea
  • Diarrhea
  • Increased blood calcium levels
  • Hirsutism
  • Deepening of the voice

Usage

What is it prescribed for?

Postmenopausal osteoporosis

Postmenopausal osteoporosis is a condition that occurs in women after menopause (end of the menstrual cycle in women) due to a drop in estrogen levels. This condition increases bone loss and reduces bone formation leading to weak bones. ETHDEC 50 MG Injection is used for the treatment of osteoporosis in postmenopausal women. The medicine prevents bone fractures and increases bone density. 

Anaemia with renal insufficiency

Kidneys make a vital hormone called erythropoietin, which signals your body to make red blood cells. When you have kidney problems, your kidneys cannot make enough erythropoietin which can cause a drop in your red blood cell count leading to anaemia. ETHDEC 50 MG Injection is used for the management of anaemia due to impaired kidney function. The medicine promotes the production of red blood cells.

Debilitating illness

ETHDEC 50 MG Injection is also used for a speedy recovery from an illness that seriously affects the strength of the person. The medicine correct defective protein metabolism following surgery, burns or major illness, thereby improving recovery.

Concerns

Commonly asked questions

How long does it take for this medicine to take effect?

The time taken by ETHDEC 50 MG Injection to produce effects can vary. If no satisfactory response is observed with the treatment, consult with your doctor. Do not stop the treatment or change the dosage without consulting with your doctor.

How long do the effects of this medicine last?

The effects of ETHDEC 50 MG Injection last up to 30 days.

Is it safe to consume alcohol while taking this medicine?

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Is this a habit forming medicine?

ETHDEC 50 MG Injection is known to have habit forming tendency and abuse potential.

Can this medicine be taken during pregnancy?

If you are pregnant or intending to get pregnant, you should avoid using ETHDEC 50 MG Injection since it has been found to have harmful effects on the foetus.

Can this medicine be taken while breast-feeding?

Use of ETHDEC 50 MG Injection is not recommended if you are breastfeeding an infant. However, if it becomes absolutely necessary to use this medicine, then breastfeeding should be discontinued. Consult your doctor before taking this medicine.

When not to use?

Allergy

ETHDEC 50 MG Injection is not recommended if you have a known history of allergy to Nandrolone or any other ingredient present with it. The dosage forms may contain Arachis oil (groundnut oil) and hence is not recommended if you are allergic to peanuts or soya as it can lead to allergic symptoms like rashes, redness, swelling, hives (itchy, painful eruptions that sting), etc. Seek immediate medical attention if you develop these symptoms after taking this medicine.

Cancer of the breast/prostate

ETHDEC 50 MG Injection is not recommended for males who have a carcinoma of the breast or the prostate, as this medicine can increase the severity of their condition.

Nephrosis

Nephrosis is a degenerative condition caused by any underlying factors that impair kidney function. ETHDEC 50 MG Injection is not recommended if you have nephrosis of the kidneys, as it can worsen your condition.

Breast cancer with hypercalcemia

ETHDEC 50 MG Injection is not recommended in females having breast cancer who also have high levels of calcium in the body.

Warnings

Warnings for special population

Pregnancy

If you are pregnant or intending to get pregnant, you should avoid using ETHDEC 50 MG Injection since it has been found to have harmful effects on the foetus.

Breast-feeding

Use of ETHDEC 50 MG Injection is not recommended if you are breastfeeding an infant. However, if it becomes absolutely necessary to use this medicine, then breastfeeding should be discontinued. Consult your doctor before taking this medicine.

General warnings

Peanut allergy

ETHDEC 50 MG Injection may contain Arachis oil which is obtained from peanuts and hence should not be used if you are allergic to peanuts or soya.

Virilisation

ETHDEC 50 MG Injection can cause Virilisation (development of male sexual characteristics in a female) which could make a woman's voice hoarse, lead to the development of excess facial and body hair, cause irregular menstruation, etc. Hence this medicine should be used with caution.

Paediatric use

ETHDEC 50 MG Injection should not be administered to children and adolescents who are yet to attain puberty. Use of this medicine could interfere with the growth and sexual development process.

Misuse by sportsperson

ETHDEC 50 MG Injection should not be used by sportspersons or body builders to enhance performance and muscle growth as the risk of adverse effects are very high. The World anti-doping agency and other sports bodies have banned the use of this medicine by active sportspersons.

Other disease

ETHDEC 50 MG Injection works by improving the tissue building and protein formation capacity of the body. Hence, it is likely to impact your other pre-existing health conditions. Report the incidence of any disease especially of the heart and blood vessels, cancers, metabolic disorders to the doctor before receiving this medicine.

Other medicine

ETHDEC 50 MG Injection is known to interact with many other medications that you might possibly be using. Report the use of all medicines including supplements and herbs to the doctor to ensure safety and efficacy.

Increased libido

ETHDEC 50 MG Injection can cause an increase in sexual urges in men. Report instances of frequent and painful erections to the doctor.

Dosage

Missed Dose

It is important to stick with the schedule for your ETHDEC 50 MG Injection shot. If you missed taking the shot, inform your doctor as soon as you remember, and get an appointment to make up for the missed dose.

Overdose

It is administered in a proper healthcare setting by specialized healthcare professionals so the likelihood of an overdose is rare. Contact your doctor if an overdose with nandrolone is suspected.

Interactions

All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.

Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Interaction with Medicine

  • Dexamethasone
  • Warfarin
  • Leflunomide
  • Insulin

Disease interactions

Carcinoma in males

Use of ETHDEC 50 MG Injection is not recommended in males having cancer of the breast or prostate. This medicine may accelerate tumour growth worsening cancer. Inform your doctor before taking this medicine, he/she may suggest any safe alternative treatment option.

Fluid Retention and oedema

Use of ETHDEC 50 MG Injection is known to cause fluid retention in the body and hence should be administered cautiously in patients having fluid retention disease or oedema.

Hyperlipoproteinemia

Use of ETHDEC 50 MG Injection can interfere with the fat and cholesterol levels in the body and may significantly increase the risk of damage to the heart and blood vessels. Hence, it should be used with extreme caution if you have high fat and lipid levels or medical conditions of the heart and blood vessels.

Liver disease

ETHDEC 50 MG Injection should be used with extreme caution in people having impaired liver function or other liver problems. Suitable dose adjustments and clinical safety monitoring are recommended in such cases.

Bleeding disorders

This medicine can interfere with normal blood clotting and hence should be administered cautiously in people with pre-existing bleeding disorders.

Diabetes

ETHDEC 50 MG Injection can lower the blood sugar levels and hence should be used with caution in diabetic people. Suitable dose adjustments and regular monitoring of blood glucose levels are recommended in such cases.

Food interactions

Information not available.

Lab interactions

Thyroid function test

Report the use of ETHDEC 50 MG Injection if you are about to undertake a thyroid function test as this medicine might interfere with the test results.

This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.

General Instructions

ETHDEC 50 MG Injection is administered in a proper healthcare setting by specialized healthcare professionals. Do not self administer.

This medicine may cause the development of male characteristics such as hoarseness, increased hair growth, acne and increased sex drive.

Inform your doctor if you experience any side effects such as skin rashes, redness, and swelling.

Do not take ETHDEC 50 MG Injection  if you are pregnant, planning to conceive, or breastfeeding.

Other Details

Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

Does not cause sleepiness

How it works

ETHDEC 50 MG Injection mimics the action of the sex hormone (chemical messenger in the body) testosterone, a hormone that promotes the growth of the tissues and protein formation in the body. The medicine strengthens the bones and also promotes the production of red blood cells.

Classification

Category

Androgens and anabolic steroids

Schedule

Schedule H

References

Pubchem.ncbi.nlm.nih.gov. 2021. Nandrolone. [online] Available at: < [Accessed 4 August 2021].

https://pubchem.ncbi.nlm.nih.gov/compound/9904>

Dailymed.nlm.nih.gov. 2021. DailyMed - nandrolone decanoate- Nandrolone Decanoate injection. [online] Available at: < [Accessed 4 August 2021].

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a586b484-1b46-40b9-9508-fd28002ad383>

Medicines.org.uk. 2021. [online] Available at: < [Accessed 4 August 2021].

https://www.medicines.org.uk/emc/files/pil.5374.pdf>

Mayoclinic.org. 2021. Anabolic Steroid (Oral Route, Parenteral Route) Proper Use - Mayo Clinic. [online] Available at: < [Accessed 4 August 2021].

https://www.mayoclinic.org/drugs-supplements/anabolic-steroid-oral-route-parenteral-route/proper-use/drg-20069323>

Ebs.tga.gov.au. 2021. TGA eBS - Product and Consumer Medicine Information Licence. [online] Available at: < [Accessed 4 August 2021].

https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-PI-04219-3>

bottom of page